We are looking forward to the BSGCT (British Society for Gene & Cell Therapy) Annual Conference 2026 in Newcastle, United Kingdom, on 17–18 April 2026.

This leading UK event brings together scientists, clinicians, and industry innovators to explore the latest breakthroughs in gene and & cell therapy, —from translational research to early‑phase clinical development and emerging therapeutic platforms.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Advances in gene and & cell therapy development
  • Translational pathways from preclinical findings to first‑in‑human studies
  • Safety and regulatory considerations for next‑generation therapies
  • Biomarker‑driven approaches to early‑phase trials
  • Collaboration between academic groups, biotech innovators, and clinical researchers

Connect With Us

If you are attending the BSGCT Annual Conference 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Annual Conference - BSGCT

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event